DUBAI (Reuters) – Russia’s Sputnik V vaccine induces a “robust neutralizing” antibody response to the Omicron variant, which is further strengthened by the Sputnik Light booster, the Russia Direct Investment Fund said in a statement on Friday.
A preliminary lab study by the Gamaleya Center shows that Sputnik V demonstrates “high virus neutralizing activity” against Omicron and “is expected to provide strong defence against severe disease and hospitalisation,” the statement said.
(Reporting by Yousef Saba; editing by John Stonestreet)
